Received May 22, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (VAQTA) | MERCK & CO. INC. | 2 | Z006542 | IM / RL |
| HEPA | HEP A (VAQTA) | MERCK & CO. INC. | UNK | Z006542 | — |
No symptoms reported; Nurse reported administration of an adult dose of VAQTA to a child; This spontaneous report was received from a nurse and refers to a 18-month-old patient of unknown gender. Information regarding the patient's concurrent conditions, medical history, or concomitant medications was not provided. On 19-May-2026, the patient was vaccinated with an adult dose of Hepatitis A Vaccine, Inactivated (VAQTA) 1 ml (route of administration and anatomical location not provided, lot number Z006542, which was verified to be valid, expiration date on 20-Oct-2026) for prophylaxis (Overdose). No symptoms reported (No adverse event).